Enovis to Participate in Investor Conferences in November
Enovis Corporation (NYSE: ENOV) has announced participation in two investor conferences this November. CFO Chris Hix and incoming CFO Ben Berry will speak at the Credit Suisse 31st Annual Healthcare Conference on November 8 in Rancho Palos Verdes, CA. Later, on November 29, CEO Matt Trerotola and Ben Berry will participate in the Evercore ISI 5th Annual HEALTHCONx virtual conference. Enovis specializes in medical technology and is committed to improving patient outcomes through innovative solutions.
- None.
- None.
Wilmington, DE, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will participate in two investor conferences in November.
On Tuesday, November 8, Chris Hix, CFO, and Ben Berry, incoming CFO, will participate in the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, CA.
On Tuesday, November 29, Matt Trerotola, CEO, and Ben Berry, incoming CFO, will participate in the Evercore ISI 5th Annual HEALTHCONx virtual conference.
ABOUT ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit www.enovis.com.
Contact:
Derek Leckow
Vice President, Investor Relations
Enovis Corporation
+1-302-252-9159
investorrelations@enovis.com
***
Source: Enovis Corporation
FAQ
What events is Enovis participating in November 2022?
Which executives from Enovis will participate in the investor conferences?
Where will the Credit Suisse conference be held?
What is the focus of Enovis Corporation?